Human Gene IRF3 (ENST00000601291.5) from GENCODE V44
Description: Homo sapiens interferon regulatory factor 3 (IRF3), transcript variant 2, mRNA. (from RefSeq NM_001197122) RefSeq Summary (NM_001197122): This gene encodes a member of the interferon regulatory transcription factor (IRF) family. The encoded protein is found in an inactive cytoplasmic form that upon serine/threonine phosphorylation forms a complex with CREBBP. This complex translocates to the nucleus and activates the transcription of interferons alpha and beta, as well as other interferon-induced genes. The protein plays an important in the innate immune response against DNA and RNA viruses. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2020]. Gencode Transcript: ENST00000601291.5 Gencode Gene: ENSG00000126456.16 Transcript (Including UTRs) Position: hg38 chr19:49,659,572-49,665,802 Size: 6,231 Total Exon Count: 8 Strand: - Coding Region Position: hg38 chr19:49,659,589-49,664,838 Size: 5,250 Coding Exon Count: 7
ID:IRF3_HUMAN DESCRIPTION: RecName: Full=Interferon regulatory factor 3; Short=IRF-3; FUNCTION: Key transcriptional regulator of type I interferon (IFN)-dependent immune responses and plays a critical role in the innate immune response against DNA and RNA viruses. Regulates the transcription of type I IFN genes (IFN-alpha and IFN-beta) and IFN-stimulated genes (ISG) by binding to an interferon-stimulated response element (ISRE) in their promoters. Acts as a more potent activator of the IFN-beta (IFNB) gene than the IFN-alpha (IFNA) gene and plays a critical role in both the early and late phases of the IFNA/B gene induction. Found in an inactive form in the cytoplasm of uninfected cells and following viral infection, double-stranded RNA (dsRNA), or toll-like receptor (TLR) signaling, becomes phosphorylated by IKBKE and TBK1 kinases. This induces a conformational change, leading to its dimerization and nuclear localization and association with CREB binding protein (CREBBP) to form dsRNA-activated factor 1 (DRAF1), a complex which activates the transcription of the type I IFN and ISG genes. Can activate distinct gene expression programs in macrophages and can induce significant apoptosis in primary macrophages. ENZYME REGULATION: In the absence of viral infection, maintained as a monomer in an autoinhibited state and phosphorylation disrupts this autoinhibition leading to the liberation of the DNA- binding and dimerization activities and its nuclear localization where it can activate type I IFN and ISG genes. SUBUNIT: Monomer. Homodimer; phosphorylation-induced. Heterodimer with IRF7. Interacts with CREBBP. May interact with MAVS. Interacts with IKBKE and TBK1. Interacts with TICAM1 and TICAM2. Interacts with rotavirus A NSP1 (via C-terminus); this interaction leads to the proteasome-dependent degradation of IRF3. Interacts with RBCK1. Interacts with TRIM21. Interacts with HERC5. INTERACTION: Self; NbExp=9; IntAct=EBI-2650369, EBI-2650369; Q92793:CREBBP; NbExp=3; IntAct=EBI-2650369, EBI-81215; Q9Y5Q3:MAFB; NbExp=4; IntAct=EBI-2650369, EBI-3649340; P06400:RB1; NbExp=2; IntAct=EBI-2650369, EBI-491274; P28749:RBL1; NbExp=2; IntAct=EBI-2650369, EBI-971402; O43765:SGTA; NbExp=3; IntAct=EBI-2650369, EBI-347996; Q9UHD2:TBK1; NbExp=4; IntAct=EBI-2650369, EBI-356402; SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=Shuttles between cytoplasmic and nuclear compartments, with export being the prevailing effect. When activated, IRF3 interaction with CREBBP prevents its export to the cytoplasm. TISSUE SPECIFICITY: Expressed constitutively in a variety of tissues. PTM: Constitutively phosphorylated on many serines residues. C- terminal serine/threonine cluster is phosphorylated in response of induction by IKBKE and TBK1. Ser-385 and Ser-386 may be specifically phosphorylated in response to induction. An alternate model propose that the five serine/threonine residues between 396 and 405 are phosphorylated in response to a viral infection. Phosphorylation, and subsequent activation of IRF3 is inhibited by vaccinia virus protein E3. PTM: Ubiquitinated; ubiquitination involves RBCK1 leading to proteasomal degradation. Polyubiquitinated; ubiquitination involves TRIM21 leading to proteasomal degradation. PTM: ISGylated by HERC5 resulting in sustained IRF3 activation and in the inhibition of IRF3 ubiquitination by disrupting PIN1 binding. The phosphorylation state of IRF3 does not alter ISGylation. SIMILARITY: Belongs to the IRF family. SIMILARITY: Contains 1 IRF tryptophan pentad repeat DNA-binding domain.
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on Q14653
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Gene Ontology (GO) Annotations with Structured Vocabulary
Molecular Function: GO:0000978 RNA polymerase II core promoter proximal region sequence-specific DNA binding GO:0000981 RNA polymerase II transcription factor activity, sequence-specific DNA binding GO:0001077 transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding GO:0001078 transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding GO:0001228 transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding GO:0003677 DNA binding GO:0003700 transcription factor activity, sequence-specific DNA binding GO:0003712 transcription cofactor activity GO:0005515 protein binding GO:0019904 protein domain specific binding GO:0042802 identical protein binding GO:0042803 protein homodimerization activity GO:0043565 sequence-specific DNA binding GO:0044212 transcription regulatory region DNA binding
Biological Process: GO:0000122 negative regulation of transcription from RNA polymerase II promoter GO:0002376 immune system process GO:0006351 transcription, DNA-templated GO:0006355 regulation of transcription, DNA-templated GO:0006366 transcription from RNA polymerase II promoter GO:0006915 apoptotic process GO:0006974 cellular response to DNA damage stimulus GO:0009617 response to bacterium GO:0016032 viral process GO:0031663 lipopolysaccharide-mediated signaling pathway GO:0032479 regulation of type I interferon production GO:0032480 negative regulation of type I interferon production GO:0032481 positive regulation of type I interferon production GO:0032496 response to lipopolysaccharide GO:0032727 positive regulation of interferon-alpha production GO:0032728 positive regulation of interferon-beta production GO:0035666 TRIF-dependent toll-like receptor signaling pathway GO:0039530 MDA-5 signaling pathway GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043330 response to exogenous dsRNA GO:0045087 innate immune response GO:0045351 type I interferon biosynthetic process GO:0045358 negative regulation of interferon-beta biosynthetic process GO:0045944 positive regulation of transcription from RNA polymerase II promoter GO:0050689 negative regulation of defense response to virus by host GO:0050715 positive regulation of cytokine secretion GO:0051607 defense response to virus GO:0060333 interferon-gamma-mediated signaling pathway GO:0060337 type I interferon signaling pathway GO:0060340 positive regulation of type I interferon-mediated signaling pathway GO:0071222 cellular response to lipopolysaccharide GO:0071359 cellular response to dsRNA GO:0071888 macrophage apoptotic process GO:0097300 programmed necrotic cell death
Protein Q14653 (Reactome details) participates in the following event(s):
R-HSA-1169394 ISGylation of IRF3 R-HSA-1606345 Recruitment of IRF3 to activated ZBP1:TBK1 R-HSA-1834939 STING recruits TBK1 and IRF3 R-HSA-2395992 p-T,4S-IRF3 is dimerized R-HSA-1606327 Phosphorylation and release of IRF3 R-HSA-2396007 IRF3 is phosphorylated by TBK1 R-HSA-2396002 TBK1 is phosphorylated within STING:TBK1:IRF3 complex R-HSA-3249392 NLRP4 and DTX4 associate with p-S172-TBK1 within STING:TBK1:IRF3 R-HSA-8948709 DTX4 ubiquitinates p-S172-TBK1 within NLRP4:DTX4:STING:TBK1:IRF3 R-HSA-166271 IRF3/IRF7 recruitment to p-TBK1/p-IKK epsilon bound to the activated TLR4 R-HSA-918232 Recruitment of IRF3,IRF7 R-HSA-9013979 IRF3/IRF7 recruitment to p-TBK1/p-IKK epsilon bound to the activated TLR3 R-HSA-1028816 Translocation of phosphorylated IRF3,IRF7 dimers into nucleus R-HSA-2032396 Dimerized phospho-IRF3 migrates to the nucleus R-HSA-1028821 Dimerization of Phospho IRF3 or phospho IRF7 R-HSA-168933 Dimerization of phosphorylated IRF3/IRF7 R-HSA-166245 Phosphorylation of IRF-3/IRF7 and their release from the activated TLR complex R-HSA-918229 Phosphorylation and release of IRF3/IRF7 R-HSA-9013978 Phosphorylation of IRF-3/IRF7 and their release from the activated TLR3 complex R-HSA-1028817 CREBBP, EP300 binds p-T,4S-IRF3:p-T,4S-IRF3 R-HSA-3134883 Beta-catenin enhances association of IRF3 with CBP/p300 R-HSA-1028820 Formation of VAF (virus-activated factor) complex R-HSA-936380 Interaction of PIN1 with p-IRF3 R-HSA-177671 Dimerized phospho-IRF3/IRF7 is transported to the nucleus R-HSA-1028815 p-T,4S-IRF3:p-T,4S-IRF3:CREBBP, EP300 binds promoters of Interferon-beta R-HSA-1028819 VAF/pIRF7:CBP/p300 binds the promoters of type-I IFN genes R-HSA-1169408 ISG15 antiviral mechanism R-HSA-1606341 IRF3 mediated activation of type 1 IFN R-HSA-3270619 IRF3-mediated induction of type I IFN R-HSA-3134975 Regulation of innate immune responses to cytosolic DNA R-HSA-936964 Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon R-HSA-918233 TRAF3-dependent IRF activation pathway R-HSA-9013973 TICAM1-dependent activation of IRF3/IRF7 R-HSA-909733 Interferon alpha/beta signaling R-HSA-877300 Interferon gamma signaling R-HSA-1169410 Antiviral mechanism by IFN-stimulated genes R-HSA-1606322 ZBP1(DAI) mediated induction of type I IFNs R-HSA-1834941 STING mediated induction of host immune responses R-HSA-3134973 LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production R-HSA-933541 TRAF6 mediated IRF7 activation R-HSA-936440 Negative regulators of DDX58/IFIH1 signaling R-HSA-1834949 Cytosolic sensors of pathogen-associated DNA R-HSA-937061 TRIF(TICAM1)-mediated TLR4 signaling R-HSA-168928 DDX58/IFIH1-mediated induction of interferon-alpha/beta R-HSA-168164 Toll Like Receptor 3 (TLR3) Cascade R-HSA-913531 Interferon Signaling R-HSA-168249 Innate Immune System R-HSA-166166 MyD88-independent TLR4 cascade R-HSA-168898 Toll-Like Receptors Cascades R-HSA-1280215 Cytokine Signaling in Immune system R-HSA-168256 Immune System R-HSA-166016 Toll Like Receptor 4 (TLR4) Cascade
US Server
